Universe · entity
Redmile Group, LLC
Institutional manager (13F) · CIK 1425738
13F holdings · as of 2026-03-31 · top 35 · reported portfolio $1.5B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | SCHOLAR ROCK HLDG CORP | $446M | 9,066,621 |
| 2 | KRYSTAL BIOTECH INC | $174M | 673,505 |
| 3 | STOKE THERAPEUTICS INC | $136M | 4,164,120 |
| 4 | IMMUNOME INC | $122M | 5,558,885 |
| 5 | NURIX THERAPEUTICS INC | $120M | 7,732,808 |
| 6 | ANNEXON INC | $81M | 14,549,768 |
| 7 | ADC THERAPEUTICS SA | $58M | 15,470,502 |
| 8 | REGENXBIO INC | $37M | 4,368,804 |
| 9 | SHATTUCK LABS INC | $36M | 5,539,724 |
| 10 | BEAM THERAPEUTICS INC | $29M | 1,237,659 |
| 11 | NEUROGENE INC | $29M | 1,459,599 |
| 12 | COGENT BIOSCIENCES INC | $26M | 688,036 |
| 13 | ABSCI CORPORATION | $25M | 8,253,316 |
| 14 | IDEAYA BIOSCIENCES INC | $17M | 521,117 |
| 15 | ALX ONCOLOGY HLDGS INC | $16M | 7,964,188 |
| 16 | FATE THERAPEUTICS INC | $15M | 12,872,946 |
| 17 | XENON PHARMACEUTICALS INC | $15M | 262,674 |
| 18 | SOLID BIOSCIENCES INC | $14M | 2,011,895 |
| 19 | NUVATION BIO INC | $14M | 3,153,256 |
| 20 | ZYMEWORKS INC | $12M | 491,654 |
| 21 | SILENCE THERAPEUTICS PLC | $11M | 2,164,777 |
| 22 | DBV TECHNOLOGIES S A | $10M | 491,340 |
| 23 | BIOMARIN PHARMACEUTICAL INC | $10M | 173,859 |
| 24 | CELLDEX THERAPEUTICS INC NEW | $8M | 261,508 |
| 25 | CERIBELL INC | $7M | 386,786 |
| 26 | LIVANOVA PLC | $7M | 108,354 |
| 27 | ESTABLISHMENT LABS HLDGS INC | $6M | 103,464 |
| 28 | PRIME MEDICINE INC | $6M | 1,590,832 |
| 29 | ORIC PHARMACEUTICALS INC | $5M | 415,710 |
| 30 | EUPRAXIA PHARMACEUTICALS INC | $5M | 700,000 |
| 31 | ARDELYX INC | $4M | 733,350 |
| 32 | INVIVYD INC | $3M | 2,648,659 |
| 33 | ATARA BIOTHERAPEUTICS INC | $2M | 441,701 |
| 34 | AGOMAB THERAPEUTICS NV | $2M | 156,250 |
| 35 | PLIANT THERAPEUTICS INC | $973k | 772,126 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.